Biotech-IgG Equity Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
Biotech-IgG Equity General Information
Description
Manufacturer of advanced diagnostic instruments intended to serve the healthcare markets. The company specializes in establishing T2Dx instruments for blood analysis and is engaged in the manufacture and sale of kits and reagents, immunodiagnostics instruments, diagnostic kits and other analytical instruments, thereby enabling rapid detection of sepsis and improving patient outcomes.
Contact Information
Website
www.biotech-igg.com(Operating Subsidiary)
Corporate Office
- Box 4211
- 171 04 Solna
- Sweden
Corporate Office
- Box 4211
- 171 04 Solna
- Sweden
Biotech-IgG Equity Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Biotech-IgG Equity Patents
Biotech-IgG Equity Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-1787110-A1 | Calibratable flow detector | Inactive | 25-Aug-2004 | ||
EP-1787110-A4 | Calibratable flow detector | Inactive | 25-Aug-2004 | ||
US-20080184810-A1 | Calibratable flow detector | Active | 25-Aug-2004 | ||
US-7780917-B2 | Low molecular substances can be determined qualitatively and quantitatively with the reliably calibrated flow-through detector and that this detector can be joined in direct connection with a sample outlet e.g. liquid flow from a micro-dialysis probe, filter probe, fermenter, cell suspension | Inactive | 25-Aug-2004 | ||
CA-2573071-A1 | Sire flow detector | Inactive | 08-Jul-2004 | G01N27/40 |
Biotech-IgG Equity Executive Team (3)
Name | Title | Board Seat |
---|---|---|
Johan Backman | Managing Director & Board Member | |
Glenn Renhult | Chairman |
Biotech-IgG Equity Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
Biotech-IgG Equity | Chairman | ||
Biotech-IgG Equity | Managing Director & Board Member |
Biotech-IgG Equity Signals
Biotech-IgG Equity Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Biotech-IgG Equity FAQs
-
When was Biotech-IgG Equity founded?
Biotech-IgG Equity was founded in 1996.
-
Where is Biotech-IgG Equity headquartered?
Biotech-IgG Equity is headquartered in Solna, Sweden.
-
What is the size of Biotech-IgG Equity?
Biotech-IgG Equity has 5 total employees.
-
What industry is Biotech-IgG Equity in?
Biotech-IgG Equity’s primary industry is Diagnostic Equipment.
-
Is Biotech-IgG Equity a private or public company?
Biotech-IgG Equity is a Private company.
-
What is Biotech-IgG Equity’s current revenue?
The current revenue for Biotech-IgG Equity is
. -
Who are Biotech-IgG Equity’s investors?
European Institute of Science has invested in Biotech-IgG Equity.
-
When was Biotech-IgG Equity acquired?
Biotech-IgG Equity was acquired on 23-Dec-2019.
-
Who acquired Biotech-IgG Equity?
Biotech-IgG Equity was acquired by Conquest Capital Management.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »